Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Antiglutamatergic therapy for multiple sclerosis?
Chronic peripheral nerve compression disrupts paranodal axoglial junctions.
Instructions for Completing Postreading Self-Assessment and CME Test and Tally Sheet.
Disturbed spontaneous brain-activity pattern in patients with optic neuritis using amplitude of low-frequency fluctuation: a functional magnetic resonance imaging study.
Acute disseminated encephalomyelitis secondary to serogroup B meningococcal vaccine.
Cellular distribution of glucose and monocarboxylate transporters in human brain white matter and multiple sclerosis lesions.
An Association Between Glatiramer Acetate and Malignant Melanoma.
Reversible disconnection syndrome in a case of acute tumefactive demyelinating lesion: a PET study.
Reassembly of Excitable Domains after CNS Axon Regeneration.
microRNA (miRNA)-Mediated Pathogenetic Signaling in Alzheimer's Disease (AD).
XPC deficiency is related to APE1 and OGG1 expression and function.
Month of birth, HLA-DRB1*15 locus and risk of multiple sclerosis in offspring.
Abnormal white matter microstructure and increased extracellular free-water in the cingulum bundle associated with delusions in chronic schizophrenia.
Imaging of microglial activation in MS using PET: Research use and potential future clinical application.
Multiple sclerosis animal models: A clinical and histopathological perspective.
The Montreal Cognitive Assessment (MoCA) as a screening test for cognitive dysfunction in multiple sclerosis.
Resetting the immune response after autologous hematopoietic stem cell transplantation for autoimmune diseases.
Study Confirms Natalizumab Efficacy, Safety in Treating RRMS
The best basic science paper on multiple sclerosis in 2012: Commentary.
Progressive MS Alliance Industry Forum: Maximizing Collective Impact To Enable Drug Development.
Addressing Concerns Regarding the Use of Gadolinium in a Standardized MRI Protocol for the Diagnosis and Follow-Up of Multiple Sclerosis.
Assessment of IL-17A, IL-10 and TGF-beta1 serum titers in RRMS patients treated with Avonex, possible biomarkers for treatment response.
The lymphoid chemokine, CXCL13, is dispensable for the initial recruitment of B cells to the acutely inflamed central nervous system.
Vaccination with DNA encoding an immunodominant myelin basic protein peptide targeted to Fc of immunoglobulin G suppresses experimental autoimmune encephalomyelitis.
Quantifying the relationship between increased disability and health care resource utilization, quality of life, work productivity, health care costs in patients with multiple sclerosis in the US.

Pages